Trials / Completed
CompletedNCT02352090
Synthetic vs Natural Estrogen in Combined Oral Contraception
Synthetic vs Natural Estrogen in Combined Oral Contraception- Effect on Insulin Sensitivity, Coagulation, Inflammation and Endometrium - a Comparison With a Progestin-only Preparation.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Helsinki University Central Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The main objective of the study is to compare the metabolic effects of natural estradiol and synthetic ethinylestradiol used in combined oral contraception in healthy women. A progestin-only preparation will be used in comparison. The main goal is to study the effects on glucose metabolism, coagulation and a markers of chronic inflammation (such as hs-CRP). Our hypothesis is that the natural estradiol preparation will influence blood glucose levels, markers of coagulation and chronic inflammation less than the ethinylestradiol preparation. The progestin-only preparation will not effect these parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ethinyl estradiol / dienogest | One tablet orally for 9 weeks, continuous use |
| DRUG | Estradiol valerate / dienogest | One tablet orally for 9 weeks, continuous use |
| DRUG | Dienogest | One tablet orally for 9 weeks, continuous use |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2018-12-30
- Completion
- 2018-12-30
- First posted
- 2015-02-02
- Last updated
- 2023-06-22
- Results posted
- 2021-06-29
Locations
2 sites across 1 country: Finland
Source: ClinicalTrials.gov record NCT02352090. Inclusion in this directory is not an endorsement.